The IPO Buzz: Mineralys Therapeutics Prices Upsized IPO at $16.00 – High End
Up is the word of the day. Mineralys Therapeutics (MLYS) priced its upsized IPO at $16.00 – the top of its $14.00-to-$16.00 range – on 12.0 million shares – up from 10.0 million shares in the prospectus – tonight (Thursday, Feb. 9, 2023) to raise $192 million. The 20 percent increase in the biotech IPO’s […]
February 9, 2023 Read More